MATCH SIZE AND QUANTITY
Build your comparison.
Choose a labeled amount and selection to load matching prices.
Atomik Labz
122 products · 249 listings
Daily snapshot · inspect sources
Capsule comparison
Orforglipron Capsules prices
Compare Orforglipron Capsules listings by strength, selection and supplier. Inspect the original source behind each price.
2suppliers represented
2source-linked listings
1strengths available
GO BEYOND THE PRICE
Track it. Plan it. Inspect it.
Select a strength and selection above to view price history, save a price watch or add it to your basket.
DOCUMENTATION PASSPORTS
Reports and batch records
Inspect the source report, recorded lot and document access. A report link does not confirm the batch currently shipping.
Loading documentation records…
Listed amounts and selections
- 6 mg2 suppliers · Pack counts: 60
Reported quantities in this family: 60. Counts and units must be matched to the exact listing.
Compare the exact selection
Choose the labeled amount per unit and quantity before comparing. A single unit and a multipack have different upfront prices. Keep product format and exact recipe consistent; similar names do not establish equivalent products.
Follow the original listing to check its quantity, availability and current price. Unit prices use the full labeled mass in each selection.
Suppliers with Orforglipron Capsules listings
2 profiles
Solution Peptides
153 products · 275 listings
Sources and comparison limits
2 listings from direct supplier captures. Capture and import dates record when data was obtained; they do not guarantee the supplier’s current price or stock.
Listings include out-of-stock and unconfirmed-stock records. Inclusion does not certify a supplier, a batch or a product. Read how matching and source dates work.
Explore more capsule listings
FROM PEPTIDES CALCULATOR
About Orforglipron
Source profile reviewed 2026-10-01 · Imported 2026-10-22. Read the full compound profile
Orforglipron (Foundayo, development code LY3502970) is a once-daily oral GLP-1 receptor agonist, originally discovered at Chugai Pharmaceutical and out-licensed in 2018. Unlike semaglutide and tirzepatide it is not a peptide at all but a small synthetic molecule that activates the same receptor, which is why it can be swallowed as an ordinary tablet with no food, water or refrigeration restrictions. The FDA approved it in April 2026 for long-term weight management in adults with obesity, or overweight plus a weight-related condition, alongside a reduced-calorie diet and more physical activity; regulatory submissions for weight management and type 2 diabetes are pending elsewhere. Its phase 3 programme is unusually large for a new entrant, covering obesity (ATTAIN), type 2 diabetes (ACHIEVE) and ongoing trials in sleep apnoea, hypertension, osteoarthritis pain and peripheral arterial disease.
- Formula
- C48 H48 F2 N10 O5
- Molar mass
- 883 g/mol
- CAS number
- 2212020-52-3
Research evidence described in the source
Research Status & Clinical Development
Current development stage and why no consumer dosing guide is shown
Mechanism of Action
How orforglipron works as an oral GLP-1 receptor agonist
Why Orforglipron Matters
What makes it different from older oral and injectable GLP-1 options
Clinical Trial Findings
Weight loss and glycemic-control outcomes described in the provided article
Limitations noted in the source
- Safety & Tolerability: The main limitation highlighted by the current source
Publications and references linked by the source
- pubchem.ncbi.nlm.nih.gov/compound/137319706
- dailymed.nlm.nih.gov/dailymed/drugInfo.cfm
- pubmed.ncbi.nlm.nih.gov/42479349/
- pubmed.ncbi.nlm.nih.gov/40960239/
- investor.lilly.com/news-releases/news-release-details/lillys-oral-glp-1-orforglipron-demonstrated-meaningful-weight
- pubmed.ncbi.nlm.nih.gov/41275875/
- pubmed.ncbi.nlm.nih.gov/40544435/
- pubmed.ncbi.nlm.nih.gov/41765029/
Background is reproduced from Peptides Calculator with attribution. The source describes compound-level research. It does not evaluate the identity, quality or suitability of a listed supplier’s product or batch.